Quantum Foundry Copenhagen has announced a 5,300-square-meter quantum chip fabrication facility backed by the Novo Nordisk Foundation. Set to open in 2027, the plant will provide commercial wafer fabrication and ultra-high-vacuum manufacturing to scale Europe's production of fault-tolerant quantum computing processors.
COPENHAGEN — Quantum Foundry Copenhagen, owned by the Novo Nordisk Foundation, has announced plans to establish a dedicated 5,300-square-meter quantum chip fabrication facility in Copenhagen, Denmark. Scheduled to become operational in 2027, the facility addresses a core manufacturing bottleneck in Europe’s deep-tech sector by bridging academic research with scaled industrial production.
The initiative is anchored by the Novo Nordisk Foundation's broader commitment of over DKK 2.9 billion (€390 million) toward quantum technologies. The new plant will combine advanced nanofabrication laboratories, material characterization, chip assembly, packaging, and ultra-high-vacuum (UHV) manufacturing to supply commercial quantum processors to global technology vendors.
Bridging Research and Industrial Scale
While Europe maintains a strong academic footprint in quantum physics, commercializing hardware components at scale has historically lagged behind global competitors. The Copenhagen plant is designed to overcome this structural gap by providing commercial wafer fabrication services for superconducting, semiconducting, and photonic components.
The facility will work in close coordination with the Novo Nordisk Foundation Quantum Computing Programme (NQCP) at the Niels Bohr Institute, University of Copenhagen. This synergy aims to accelerate Denmark's target of building a fully functional, fault-tolerant quantum computer before 2034 while providing external quantum vendors with reliable commercial production lines.
According to corporate disclosures, foundation statements, and official project briefs:
Facility Footprint: 5,300 square meters of specialized cleanrooms and UHV manufacturing floors.
Target Operational Date: Slated to open and begin initial production cycles by 2027.
Core Capabilities: Nanofabrication, extreme atomic purity processing, chip packaging, and commercial wafer supply.
Strategic Alignment: Directly supports the EU’s evolving policy focus on technological sovereignty and commercial manufacturing.
Official Sources Section
Quote Section
"According to Quantum Foundry Copenhagen CEO Peter Krogstrup, the company's vision is to become a world-leading quantum chip manufacturer, supplying Europe with advanced processors and enabling ecosystem vendors to scale production sustainably."
Why It Matters
For the European technology ecosystem, the establishment of a dedicated commercial quantum foundry reduces reliance on overseas fabrication facilities. For businesses and researchers, accessible local chip manufacturing cuts down development cycles for next-generation systems designed to solve complex challenges in medicine, cryptography, and materials science.
Key Facts at a Glance
Project Owner: Quantum Foundry Copenhagen (owned by the Novo Nordisk Foundation).
Investment Scale: Built upon the Foundation's DKK 2.9 billion+ commitment to quantum tech.
Core Focus: Wafer fabrication using extreme atomic precision and ultra-high-vacuum processes.
Ecosystem Impact: Strengthens European technological sovereignty and commercial supply chains.
FAQ Section
What is the primary objective of Quantum Foundry Copenhagen's new facility?
The 5,300-square-meter facility aims to provide commercial wafer fabrication, packaging, and UHV manufacturing services for quantum technology vendors globally.
When is the chip fabrication plant expected to open?
The facility is scheduled to open and become operational by 2027.
Who is funding the construction of the quantum chip foundry?
The project is financed through the Novo Nordisk Foundation as part of its extensive DKK 2.9 billion commitment to regional quantum development.
Where can stakeholders track partnership and foundry updates?
Official announcements and engagement details are published directly via the Quantum Foundry Copenhagen Portal and the Novo Nordisk Foundation Site.
Source: Novo Nordisk Foundation, Quantum Foundry Copenhagen, The Next Web Technology Desk, Quantum Computing Report